CARROLLTON, Texas (PRWEB) December 08, 2017
Airway Management, the medical device manufacturer of TAP Sleep Care products, announced a new partnership with Itamar Medical Ltd, the industry’s leader in diagnostic technology. The agreement involves the distribution of Airway Management’s highly innovative, myTAP and will expand Airway’s presence into the cardiac segment within the United States with a reputable company and solid sales force.
“Itamar is a strong addition to Airway Management’s medical partnerships. We are thrilled to work with their focused and driven sales force to take the TAP Sleep Care system into the cardiac market. Their support of the TAP Systems’ reach and growth in the sleep industry will improve patient options and outcomes.” says Charles Collins, CEO of Airway Management.
Gilad Glick, CEO and President of Itamar Medical said, “I am very excited that Airway Management, with their excellent temporary oral appliance solution, has decided to join forces with us alongside our many other partners to provide Cardiac patients with fast, convenient, and cost-effective solutions to their sleep apnea co-morbidity, which was proven to be a major risk factor and progression accelerator to their cardiology disease.”
About Airway Management:
At Airway Management, we are committed to improving the health, well-being and quality of life for people who suffer from sleep-disordered breathing. We fully support clinicians, health care professionals and laboratory technicians in this endeavor. Our TAP Sleep Care System is a comprehensive suite of devices to mitigate sleep-disordered breathing that has the most independent peer-reviewed studies and the best patient outcomes compared to any other oral appliance.
About Itamar Medical Ltd.:
Itamar Medical Ltd., a publicly traded medical device Company (TASE:ITMR) focused on deploying a cross-disciplinary model of care developed for the integration of Sleep Apnea management into the cardiac patients care pathway. Through its Total Sleep Solution (TSS) program and based on its WatchPAT™ diagnostic product line, WatchPAT accomplishes this using the PAT® signal which was proven as a simple, comprehensive, reliable and scalable alternative to airflow based technologies. TSS expands the reach of sleep services by enabling point of care variability, providing a scalable model for management of a massive volume of patients’ while reducing wait times and overall cost, and offering optimized IT systems and qualified field resources to support the vast pool of cardiac patients who are suffering from the co-morbidity of Sleep Apnea and are underdiagnosed. More information about Itamar Medical can be found online at http://www.itamar-medical.com.